Live Breaking News & Updates on Konstantinos Biliouris Morgan Stanley

Operator
Good afternoon, and welcome to the REGENXBIO First Quarter 2021 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the call over to Mr. Patrick Christmas, Chief Legal Officer of REGENXBIO. You may begin.
Patrick J. Christmas II, J.D.
Chief Legal Officer
Good afternoon, and thank you for joining us. With us today are Ken Mills, REGENXBIO s President and Chief Executive Officer; and Dr. Steve Pakola, our Chief Medical Officer. Earlier this afternoon, REGENXBIO released financial and operating results for the first quarter ended March 31, 2021. The press release reporting our financial results is available on our website at www.regenxbio.com. Today s conference call will include forward-looking statements regarding our financial outlook in addition to regulatory and product development plans. These forward-looking statements are subject to risks and uncertainties that may cause ....

United States , Gbola Amusa Chardan , Mani Foroohar , Patrickj Christmas , Gena Wang , Steve Pakola , Lisa Walter , Matthew Harrison , Gbola Amusa , Esther Rajavelu , Konstantinos Biliouris Morgan Stanley , Patrick Christmas , Gena Wang Barclays , Geoff Meacham , Exchange Commission , Morgan Stanley , Regenxbio Inc , American Society Of Cell , Alec Warren Stranahan Bank , Chief Legal Officer , Ken Mills , Chief Executive Officer , Chief Medical , Risk Factors , Chief Executive , World Symposium ,